Data / Form D filings / METABOLIC SOLUTIONS DEVELOPMENT CO LLC
METABOLIC SOLUTIONS DEVELOPMENT CO LLC: Form D filings
METABOLIC SOLUTIONS DEVELOPMENT CO LLC, a pharmaceuticals company in Kalamazoo, MI, filed 8 Form D notices with the SEC between 2009 and 2019. The latest, on February 6, 2019, reports $200,000 sold of a $200,000 offering to 15 investors.
Find out what METABOLIC SOLUTIONS DEVELOPMENT CO LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 161 EAST MICHIGAN AVENUE, 4TH FLOOR, Kalamazoo, MI, 49007
- Phone
- (269) 343-6732
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1422580
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 6, 2019 | New notice | $200,000 | $200,000 | $0 | 15 | Jan 30, 2019 | sec.gov |
| Sep 24, 2015 | Amendment | $18,400,000 | $16,135,409 | $2,264,591 | 30 | Aug 9, 2012 | sec.gov |
| Jul 18, 2014 | Amendment | $14,000,000 | $11,781,106 | $2,218,894 | 23 | Aug 9, 2012 | sec.gov |
| Feb 5, 2014 | New notice | $98,191 | $98,191 | $0 | 2 | Feb 3, 2014 | sec.gov |
| Aug 14, 2012 | New notice | $10,000,000 | $2,500,000 | $7,500,000 | 1 | Aug 9, 2012 | sec.gov |
| Aug 11, 2011 | New notice | $7,800,000 | $6,810,000 | $990,000 | 23 | Jul 29, 2011 | sec.gov |
| Oct 7, 2010 | New notice | $23,500,000 | $14,981,243 | $8,518,757 | 24 | Sep 27, 2010 | sec.gov |
| Mar 24, 2009 | New notice | $12,000,000 | $0 | $12,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Jandernoa | Director | |
| James Vanderlugt | Executive Officer | |
| Gerard Colca | Executive Officer, Director | |
| Robert Zerbe | Director | |
| Mark Olesnavage | Executive Officer, Director | |
| Rolf Kletzien | Executive Officer, Director | |
| Angeline Shashlo | Executive Officer | |
| Gerald Callahan | Executive Officer, Director | |
| Sandi Doctor | Director | |
| Stephen Benoit | Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Feb 4, 2019 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what METABOLIC SOLUTIONS DEVELOPMENT CO LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.